Searched for
ATORVASTATIN TABLETS
Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...- Over 140,000 bottles of cholesterol-lowering drug recalled: Safety concerns with Atorvastatin calcium tabletsA major recall is underway for over 140,000 bottles of Atorvastatin Calcium Tablets. This popular cholesterol medication, the generic form ...
- Alembic Pharma gets USFDA nod for generic high blood pressure treatment drugAlembic Pharmaceuticals announced that it has secured final approval from the USFDA for its generic amlodipine and atorvastatin tablets, us...
- Dr Reddy's recalls 2,980 bottles of cholesterol lowering drug in USAs per the US Food and Drug Administration's latest Enforcement report, the Hyderabad-based drug major is voluntarily recalling the affecte...
- Zydus receives final approvals from USFDA for skin ointment, heart medicineThe group also received a final nod for Amlodipine and Atorvastatin Tablets USP that is administered for heart and cholesterol-related case...
- Dr Reddy's recalls over 55K bottles of hypertension drug in USDr Reddy's Laboratories is recalling over 55,000 bottles of Amlodipine besylate and Atorvastatin calcium tablets.
- Dr Reddy's Laboratories recalls anti-seizure, hypertension drugs from US marketThe firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests.
- Dr Reddy's launches generic cholesterol-lowering drug in USDr Reddy's Laboratories shares were trading at Rs 2,594 apiece on the BSE in afternoon trade, down 1.60 per cent from its previous close.
- Ranbaxy shares settle 1.51 per cent down; market capitalisation erodes by Rs 43 croreShares of Ranbaxy Laboratories today settled for the day with losses of 1.51 %, pursuant to which the market capitalisation eroded by Rs 43...
- Ranbaxy restarts generic Lipitor production for US marketPharma major Ranbaxy Laboratories restarts production of generic cholesterol lowering drug Atorvastatin as it looks to resume supplies to U...
- Dr Reddy's launches Atorvastatin calcium tablets in USDr Reddy's said that it has launched Atorvastatin calcium tablets, a bioequivalent generic version of Lipitor tablets in the US.
- Teva Pharmaceuticals will not be launching Atorvastatin, generic version of LipitorIsrael's Teva Pharmaceuticals will not launch atorvastatin, the generic version of Lipitor, that will help Indian cos Ranbaxy and Dr Reddy'...
- Ind-Swift, Wockhardt launch Atorvastatin tablets in UKInd-Swift Laboratories today said it has launched generic formulations of Atorvastatin in the UK in collaboration with Wockhardt.
- Ranbaxy begins Atorvastation exports to USRanbaxy Laboratories has commenced exports of Atorvastation Calcium tablets to the US market from its Mohali SEZ manufacturing facility.
- Ranbaxy launches Atorvastatin in 3 European countriesRanbaxy Laboratories today said it has launched generic versions of Atorvastatin tablets, used for treating cholesterol, in Italy, Sweden a...
- Ranbaxy Laboratories launches generic Cadeut in the American marketDrug firm Ranbaxy Laboratories on Tuesday launched a generic version of Caduet, used for treating cardio vascular diseases, in the US marke...
- Ranbaxy launches low-cost version of medicine 'Lipitor'The US FDA allowed Ranbaxy to make and sell atorvastatin tablets, the chemical name of Lipitor, ending months of uncertainty.
- Pfizer drags DRL to court over Lipitor copy launchPfizer has taken Dr Reddy’s Laboratories to court to delay the launch of the Indian drug maker’s low-cost version of atorvastatin in the US...
- Gets Norway nod to market Atorvastatin eRanbaxy Laboratories (RLL) announced that the Norwegian Appeals Court has given a favourable decision for Ranbaxy in its case against Pfize...
- Ranbaxy wins on all 4 Atorvastatin Patents in NorwayRanbaxy Laboratories Limited (RLL) announced that the Norwegian Appeals Court today handed down a favorable decision for Ranbaxy in its cas...
Load More
